The development of a vaccination model using two microorganisms and its application in leprosy and leishmaniasis.
D006801:Humans; D007167:Immunotherapy; D007894:Leishmania mexicana / Q000276:immunology; D007896:Leishmaniasis / Q000276:immunology / Q000517:prevention & control / Q000628:therapy*; D007918:Leprosy / Q000276:immunology / Q000517:prevention & control / Q000628:therapy*; D008536:Meglumine / Q000627:therapeutic use; D000077485:Meglumine Antimoniate; D009166:Mycobacterium leprae / Q000276:immunology; D009942:Organometallic Compounds / Q000627:therapeutic use; D014611:Vaccination
D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate